22 hours ILMN Stock Set to Gain From Expansion of TruSight Oncology PortfolioZacks
Illumina’s new TSO 500 v2 assay aims to enable CGP of tumors, bolstering its TruSight Oncology portfolio.
XIllumina’s new TSO 500 v2 assay aims to enable CGP of tumors, bolstering its TruSight Oncology portfolio.
X